Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
2.63 x 18 2.70 x 1
Post-market by (Cboe BZX)
2.67 -0.49 (-15.51%) 04/22/25 [NASDAQ]
2.63 x 18 2.70 x 1
Post-market 2.74 +0.07 (+2.62%) 19:59 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.61
Day High
4.42
Open 3.50
Previous Close 3.16 3.16
Volume 1,862,300 1,862,300
Avg Vol 4,722,265 4,722,265
Stochastic %K 49.48% 49.48%
Weighted Alpha -82.29 -82.29
5-Day Change -0.59 (-18.10%) -0.59 (-18.10%)
52-Week Range 1.41 - 35.99 1.41 - 35.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,654
  • Shares Outstanding, K 1,473
  • Annual Sales, $ 680 K
  • Annual Income, $ -7,950 K
  • EBIT $ -10 M
  • EBITDA $ -6 M
  • 60-Month Beta 3.41
  • Price/Sales 15.67
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.31
  • Number of Estimates 1
  • High Estimate -1.31
  • Low Estimate -1.31
  • Prior Year 1.80
  • Growth Rate Est. (year over year) -172.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.61 +65.84%
on 04/07/25
Period Open: 1.77
4.42 -39.59%
on 04/22/25
+0.90 (+50.85%)
since 03/21/25
3-Month
1.41 +89.36%
on 03/10/25
Period Open: 4.10
6.00 -55.50%
on 01/29/25
-1.43 (-34.89%)
since 01/22/25
52-Week
1.41 +89.36%
on 03/10/25
Period Open: 15.07
35.99 -92.58%
on 07/19/24
-12.40 (-82.29%)
since 04/22/24

Most Recent Stories

More News
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
60 Degrees Pharmaceuticals Announces 2024 Annual Results

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / February 21, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Fathom Holdings Inc. (Nasdaq:FTHM) on the RedChip Small...

FTHM : 0.7800 (+4.00%)
SXTP : 2.67 (-15.51%)
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 2.67 (-15.51%)
SXTPW : 0.0585 (+6.75%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 1.6700 (+0.60%)
SXTP : 2.67 (-15.51%)
GRRR : 17.42 (+2.83%)
CNTM : 0.6799 (+6.63%)
OSTX : 1.5200 (+2.01%)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 5.67
2nd Resistance Point 5.04
1st Resistance Point 3.86
Last Price 2.67
1st Support Level 2.05
2nd Support Level 1.42
3rd Support Level 0.24

See More

52-Week High 35.99
Fibonacci 61.8% 22.78
Fibonacci 50% 18.70
Fibonacci 38.2% 14.62
Last Price 2.67
52-Week Low 1.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro